Details for New Drug Application (NDA): 216948
✉ Email this page to a colleague
The generic ingredient in NELARABINE is nelarabine. There are two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the nelarabine profile page.
Summary for 216948
Tradename: | NELARABINE |
Applicant: | Msn |
Ingredient: | nelarabine |
Patents: | 0 |
Pharmacology for NDA: 216948
Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Suppliers and Packaging for NDA: 216948
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NELARABINE | nelarabine | INJECTABLE;INTRAVENOUS | 216948 | ANDA | Novadoz Pharmaceuticals LLC | 72205-154 | 72205-154-01 | 1 VIAL in 1 CARTON (72205-154-01) / 50 mL in 1 VIAL |
NELARABINE | nelarabine | INJECTABLE;INTRAVENOUS | 216948 | ANDA | Novadoz Pharmaceuticals LLC | 72205-154 | 72205-154-04 | 6 VIAL in 1 CARTON (72205-154-04) / 50 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 250MG/50ML (5MG/ML) | ||||
Approval Date: | Sep 13, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription